Page last updated: 2024-09-03

gefitinib and Chronic Disease

gefitinib has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chadjichristos, C; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Guerrot, D; Helle, F; Jouzel, C; Placier, S	1

Other Studies

1 other study(ies) available for gefitinib and Chronic Disease

Article	Year
Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism. American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:1 Topics: Animals; Arterioles; Blood Pressure; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Quinazolines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction	2009

Article

Year

Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.

American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:1

Topics: Animals; Arterioles; Blood Pressure; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Quinazolines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction

2009